These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 20002177

  • 1. Adjuvants in tuberculosis vaccine development.
    Moreno-Mendieta SA, Rocha-Zavaleta L, Rodriguez-Sanoja R.
    FEMS Immunol Med Microbiol; 2010 Feb; 58(1):75-84. PubMed ID: 20002177
    [Abstract] [Full Text] [Related]

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 3. Is intranasal vaccination a feasible solution for tuberculosis?
    Giri PK, Khuller GK.
    Expert Rev Vaccines; 2008 Nov; 7(9):1341-56. PubMed ID: 18980538
    [Abstract] [Full Text] [Related]

  • 4. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H, Umemura M, Okamoto Y, Yahagi A, Goga H, Harakuni T, Matsuzaki G, Arakawa T.
    Vaccine; 2008 Feb 13; 26(7):924-32. PubMed ID: 18192091
    [Abstract] [Full Text] [Related]

  • 5. Tuberculosis: vaccines in the pipeline.
    Ly LH, McMurray DN.
    Expert Rev Vaccines; 2008 Jul 13; 7(5):635-50. PubMed ID: 18564018
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P, Majlessi L, Brosch R, Smith D, Bancroft G, Clark S, Williams A, Leclerc C, Cole ST.
    J Infect Dis; 2004 Jul 01; 190(1):115-22. PubMed ID: 15195250
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
    Xing Z, Charters TJ.
    Expert Rev Vaccines; 2007 Aug 01; 6(4):539-46. PubMed ID: 17669008
    [Abstract] [Full Text] [Related]

  • 12. Tuberculosis vaccine research: the impact of immunology.
    Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC.
    Curr Opin Immunol; 2009 Jun 01; 21(3):331-8. PubMed ID: 19505813
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Novel tuberculosis vaccines on the horizon.
    Parida SK, Kaufmann SH.
    Curr Opin Immunol; 2010 Jun 01; 22(3):374-84. PubMed ID: 20471231
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vaccine adjuvant: it makes the difference.
    Lima KM, dos Santos SA, Rodrigues JM, Silva CL.
    Vaccine; 2004 Jun 23; 22(19):2374-9. PubMed ID: 15193397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.